DYAI
DYADIC INTL (DYAI)
NASDAQ
$0.70-$0.005 (-0.71%)
Price as of Jun 03, 2026 7:47 PM EDT
  • $29.4M
    Market Cap
  • -31.37%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
967,311
N/A
0
-100.00%
2.9M
-1.07%
2.9M
-26.91%
Cost of Revenue
1.0M
-16.27%
1.2M
-39.54%
2.0M
-6.94%
2.1M
+9.19%
Gross Profit
-32,952
-97.24%
-1.2M
-229.43%
922,957
+14.35%
807,110
-60.91%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-2.2M
+5.40%
-2.0M
-38.00%
-3.3M
-26.75%
-4.5M
-46.36%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
10.3M
+9.44%
9.4M
-15.57%
11.1M
-15.02%
13.1M
-23.56%
Operating Profit
-7.2M
+21.90%
-5.9M
-28.30%
-8.2M
-19.04%
-10.2M
-30.97%
Interest Income
284,085
-37.84%
456,992
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
284,085
-37.84%
456,992
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
-171,812
-287.44%
91,663
-93.61%
1.4M
+233.23%
430,420
-74.03%
Income before Taxes
-7.2M
+21.90%
-5.9M
-28.30%
-8.2M
-19.04%
-10.2M
-22.22%
Income Taxes
N/A
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-7.4M
+26.78%
-5.8M
-14.51%
-6.8M
-30.20%
-9.7M
-25.52%
Net Income from Continuing Operations Applicable to Common
N/A
N/A
-5.8M
-14.51%
-6.8M
-30.20%
-9.7M
-25.52%
Basic EPS and Net Income
-0.23
+15.00%
-0.20
-16.67%
-0.24
-29.41%
-0.34
-27.66%
Diluted EPS and Net Income
-0.23
+15.00%
-0.20
-16.67%
-0.24
-29.41%
-0.34
-27.66%
Basic Weighted Average Shares
32.6M
+11.28%
29.3M
+1.80%
28.8M
+1.53%
28.4M
+1.89%
Diluted Weighted Average Shares
32.6M
N/A
N/A
N/A
28.8M
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
4.6M
-28.96%
6.5M
-0.13%
6.5M
+12.44%
5.8M
-63.21%
Short-Term Investments
2.7M
-2.95%
2.8M
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
7.3M
-21.17%
9.3M
+42.56%
6.5M
+12.44%
5.8M
-63.21%
Total Current Assets
9.9M
+0.70%
9.8M
+21.82%
8.1M
-39.89%
13.4M
-36.11%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
10,537
+1.36%
10,396
-0.63%
10,462
+73.07%
6,045
-1.18%
Total Assets
9.9M
+0.16%
9.9M
+20.82%
8.2M
-40.06%
13.7M
-35.62%
Income Taxes Payable
967,974
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
3.7M
+50.62%
2.4M
+8.71%
2.3M
-8.04%
2.4M
-4.19%
Total Long-Term Debt
3.0M
-24.27%
3.9M
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
2.1M
+5,960.95%
34,621
-61.04%
88,870
N/A
N/A
N/A
Total Liabilities
8.7M
+16.80%
7.5M
+218.71%
2.3M
-10.84%
2.6M
-9.75%
Retained Earnings
-93.5M
+8.55%
-86.1M
+7.24%
-80.3M
+9.25%
-73.5M
+15.27%
Total Stockholders Equity
1.2M
-50.11%
2.5M
-57.98%
5.9M
-46.98%
11.1M
-39.71%
Total Shares Outstanding
36.2M
+21.29%
29.8M
+3.56%
28.8M
+0.87%
28.6M
+1.18%
Cash Flow
Cash from Operating Activities
-5.7M
+43.46%
-4.0M
-40.91%
-6.7M
-16.79%
-8.1M
-28.32%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
82,085
+104.37%
-1.9M
-125.18%
7.4M
+414.44%
-2.4M
-145.37%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
5.0M
-15.11%
5.8M
N/A
0
-100.00%
543,591
-55.81%
Financials Ratio
Gross Margin
-3.41%
N/A
N/A
N/A
31.84%
+15.60%
27.54%
-46.52%
Operating Margin
-743.59%
N/A
N/A
N/A
-283.90%
-18.16%
-346.92%
-5.56%
Return on Assets
-74.11%
+15.76%
-64.01%
+3.30%
-61.97%
+11.43%
-55.61%
+9.29%
Return on Equity
-397.80%
+185.86%
-139.16%
+73.72%
-80.11%
+21.28%
-66.05%
+18.35%
Revenue Growth
N/A
N/A
-100.00%
+9,203.19%
-1.07%
-96.01%
-26.91%
-123.92%
Current Ratio
2.68
-33.14%
4.01
+12.06%
3.58
-34.64%
5.48
-33.32%
Cash Ratio
1.25
-52.84%
2.66
-8.13%
2.89
+22.27%
2.37
-61.60%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow